WO1994029471A1
(en)
|
1993-06-10 |
1994-12-22 |
Genetic Therapy, Inc. |
Adenoviral vectors for treatment of hemophilia
|
DE69535178T2
(de)
*
|
1994-06-10 |
2006-12-14 |
Genvec, Inc. |
Adenoviren-vektor systeme und zelllinien
|
US6281010B1
(en)
|
1995-06-05 |
2001-08-28 |
The Trustees Of The University Of Pennsylvania |
Adenovirus gene therapy vehicle and cell line
|
US5756283A
(en)
*
|
1995-06-05 |
1998-05-26 |
The Trustees Of The University Of Pennsylvania |
Method for improved production of recombinant adeno-associated viruses for gene therapy
|
US6004797A
(en)
*
|
1995-11-09 |
1999-12-21 |
Avigen, Inc. |
Adenovirus helper-free recombinant AAV Virion production
|
EP0951553B1
(en)
*
|
1996-07-05 |
2003-10-29 |
Philip E. Branton |
Adenovirus e4 proteins for inducing cell death
|
US6730662B1
(en)
|
1996-07-05 |
2004-05-04 |
Mcgill University |
Adenovirus E4 proteins for inducing cell death
|
US7232899B2
(en)
|
1996-09-25 |
2007-06-19 |
The Scripps Research Institute |
Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use
|
CA2266342C
(en)
*
|
1996-09-25 |
2010-06-08 |
Novartis Ag |
Packaging cell lines for use in facilitating the development of high-capacity adenoviral vectors
|
US6544769B1
(en)
|
1996-12-13 |
2003-04-08 |
Schering Corporation |
Compostions comprising viruses and methods for concentrating virus preparations
|
US6261823B1
(en)
|
1996-12-13 |
2001-07-17 |
Schering Corporation |
Methods for purifying viruses
|
US6146891A
(en)
|
1997-01-31 |
2000-11-14 |
Schering Corporation |
Methods for cultivating cells and propagating viruses
|
US6168944B1
(en)
|
1997-01-31 |
2001-01-02 |
Schering Corporation |
Methods for cultivating cells and propagating viruses
|
CA2283253A1
(en)
*
|
1997-03-04 |
1998-09-11 |
Baxter International Inc. |
Adenovirus e1-complementing cell lines
|
US6638502B1
(en)
|
1997-04-28 |
2003-10-28 |
Gencell Sas |
Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors
|
DE69838644T2
(de)
|
1997-06-23 |
2009-05-14 |
The University Of Saskatchewan |
Verfahren zur herstellung eines rekombinanten rinderadenovirus-vektors
|
DE69926729T2
(de)
|
1998-01-08 |
2006-06-08 |
Aventis Pharmaceuticals Inc. |
Transgenes kaninchen, dass ein funktionelles menschliches lipoprotein(a) exprimiert
|
WO1999041399A1
(en)
*
|
1998-02-17 |
1999-08-19 |
Genzyme Corporation |
Methods for purified aav vector production
|
FR2777570A1
(fr)
*
|
1998-04-17 |
1999-10-22 |
Transgene Sa |
Mutant ayant une activite phosphoribosyl transferase
|
US6225456B1
(en)
|
1998-05-07 |
2001-05-01 |
University Technololy Corporation |
Ras suppressor SUR-5
|
US6506889B1
(en)
|
1998-05-19 |
2003-01-14 |
University Technology Corporation |
Ras suppressor SUR-8 and related compositions and methods
|
GB9811171D0
(en)
*
|
1998-05-22 |
1998-07-22 |
Royal Free Hosp School Med |
Viral vector
|
GB9811172D0
(en)
*
|
1998-05-22 |
1998-07-22 |
Royal Free Hosp School Med |
Virus production
|
JP2002528128A
(ja)
*
|
1998-11-02 |
2002-09-03 |
ユニバーシティ オブ サスカチュワン |
組換えアデノウイルスベクターの増殖のためのアデノウイルス必須機能を発現するウシ細胞
|
US6441156B1
(en)
*
|
1998-12-30 |
2002-08-27 |
The United States Of America As Represented By The Department Of Health And Human Services |
Calcium channel compositions and methods of use thereof
|
ES2296615T3
(es)
|
1999-04-08 |
2008-05-01 |
Antisoma Research Limited |
Actividad antiproliferativa de oligonucleotidos ricos en g y procedimiento de uso de los mismos para su union a la nucleolina.
|
US7960540B2
(en)
|
1999-04-08 |
2011-06-14 |
Advanced Cancer Therapeutics, Llc |
Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
|
US8114850B2
(en)
|
1999-04-08 |
2012-02-14 |
Advanced Cancer Therapeutics, Llc |
Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
|
FR2794771B1
(fr)
|
1999-06-11 |
2001-08-10 |
Aventis Pharma Sa |
Adenovirus recombinants codant pour le transporteur specifique de l'iode (nis)
|
ATE486089T1
(de)
|
2000-03-31 |
2010-11-15 |
Aventis Pharma Inc |
Nuklearfaktor kb induzierender faktor
|
GB0018307D0
(en)
|
2000-07-26 |
2000-09-13 |
Aventis Pharm Prod Inc |
Polypeptides
|
US7198924B2
(en)
|
2000-12-11 |
2007-04-03 |
Invitrogen Corporation |
Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
|
DE10066104A1
(de)
*
|
2000-09-08 |
2003-01-09 |
Medigene Ag |
Wirtszellen zur Verpackung von rekombinantem Adeno-assoziiertem Virus (rAAV), Verfahren zu ihrer Herstellung und deren Verwendung
|
ES2359625T3
(es)
|
2000-12-28 |
2011-05-25 |
Wyeth Llc |
Proteina protectora recombinante de.
|
AUPR518501A0
(en)
|
2001-05-22 |
2001-06-14 |
Unisearch Limited |
Yin yang-1
|
US6677156B2
(en)
|
2001-07-23 |
2004-01-13 |
Genvec, Inc. |
Non-adenoviral gene product-based complementing cells for adenoviral vectors
|
US6682929B2
(en)
|
2001-07-23 |
2004-01-27 |
Genvec, Inc. |
Adenovector complementing cells
|
US7647184B2
(en)
*
|
2001-08-27 |
2010-01-12 |
Hanall Pharmaceuticals, Co. Ltd |
High throughput directed evolution by rational mutagenesis
|
US20030129203A1
(en)
*
|
2001-08-27 |
2003-07-10 |
Nautilus Biotech S.A. |
Mutant recombinant adeno-associated viruses
|
AU2002332736A1
(en)
*
|
2001-08-30 |
2003-03-18 |
The Government Of The United States Of America, As Represented By The Secretary Of The Department Of |
New adenovirus type 7 vectors
|
US20040023910A1
(en)
*
|
2001-09-28 |
2004-02-05 |
Zhiming Zhang |
Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
|
MX339524B
(es)
|
2001-10-11 |
2016-05-30 |
Wyeth Corp |
Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
|
US20030224404A1
(en)
*
|
2002-02-25 |
2003-12-04 |
Manuel Vega |
High throughput directed evolution of nucleic acids by rational mutagenesis
|
ES2310247T3
(es)
*
|
2002-04-25 |
2009-01-01 |
Crucell Holland B.V. |
Vectores adenovirales estables y metodos de propagacion de los mismos.
|
ATE412778T1
(de)
|
2002-05-15 |
2008-11-15 |
Integragen Sa |
Humanes fettleibigkeit suszeptibilitätsgen und deren verwendungen
|
US7217796B2
(en)
|
2002-05-24 |
2007-05-15 |
Schering Corporation |
Neutralizing human anti-IGFR antibody
|
CA2495546A1
(en)
*
|
2002-08-22 |
2004-03-04 |
Merck & Co., Inc. |
Methods for propagating adenovirus and virus produced thereby
|
US20060020396A1
(en)
*
|
2002-09-09 |
2006-01-26 |
Rene Gantier |
Rational directed protein evolution using two-dimensional rational mutagenesis scanning
|
US20050202438A1
(en)
*
|
2002-09-09 |
2005-09-15 |
Rene Gantier |
Rational directed protein evolution using two-dimensional rational mutagenesis scanning
|
DE60332358D1
(de)
*
|
2002-09-09 |
2010-06-10 |
Hanall Pharmaceutical Co Ltd |
Protease-resistente modifizierte interferon alpha polypeptide
|
US20080124360A1
(en)
|
2003-01-24 |
2008-05-29 |
Seggern Daniel J Von |
Adenovirus particles with enhanced infectivity of dendritic cells and particles with decreased infectivity of hepatocytes
|
US7186699B2
(en)
*
|
2003-06-03 |
2007-03-06 |
Cell Genesys, Inc. |
Method for treating cancer by vector-mediated delivery of one or more anti-angiogenic or pro-apoptotic genes
|
US7485291B2
(en)
*
|
2003-06-03 |
2009-02-03 |
Cell Genesys, Inc. |
Compositions and methods for generating multiple polypeptides from a single vector using a virus derived peptide cleavage site, and uses thereof
|
WO2005017149A1
(en)
*
|
2003-06-03 |
2005-02-24 |
Cell Genesys, Inc. |
Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site
|
ES2391975T3
(es)
*
|
2003-07-25 |
2012-12-03 |
Genvec, Inc. |
Vacunas a base de vector adenovírico
|
PT1656458E
(pt)
|
2003-08-22 |
2009-06-24 |
Integragen Sa |
Gene humano de susceptibilidade ao autismo e suas utilizações
|
ATE458500T1
(de)
|
2003-11-14 |
2010-03-15 |
Genvec Inc |
Pharmazeutische verbindung zur behandlung von lokal fortgeschrittenem primär inoperablen pankreaskarzinom (lapc).
|
EP1697534B1
(en)
|
2003-12-01 |
2010-06-02 |
Life Technologies Corporation |
Nucleic acid molecules containing recombination sites and methods of using the same
|
CA2553541C
(en)
*
|
2004-01-23 |
2015-04-21 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
Chimpanzee adenovirus vaccine carriers
|
US7432057B2
(en)
|
2004-01-30 |
2008-10-07 |
Michigan State University |
Genetic test for PSE-susceptible turkeys
|
JP2007532656A
(ja)
|
2004-04-12 |
2007-11-15 |
アメリカ合衆国 |
アデノウイルスベクターを用いて免疫応答を誘導するための方法
|
JP2008504838A
(ja)
|
2004-07-01 |
2008-02-21 |
アンテグラジャン |
Prkcb1をコードするヒト自閉症感受性遺伝子およびその使用
|
US7604798B2
(en)
|
2004-07-15 |
2009-10-20 |
Northwestern University |
Methods and compositions for importing nucleic acids into cell nuclei
|
WO2006020071A2
(en)
|
2004-07-16 |
2006-02-23 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Vaccines against aids comprising cmv/r-nucleic acid constructs
|
WO2006039045A2
(en)
*
|
2004-09-01 |
2006-04-13 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Adenoviral vectors able to transduce apcs, potential use in immune response generation
|
US20060057127A1
(en)
*
|
2004-09-10 |
2006-03-16 |
Pocheng Liu |
Cytokine-expressing cellular vaccines for treatment of prostate cancer
|
DE602006017045D1
(de)
|
2005-03-24 |
2010-11-04 |
Integragen Sa |
Ein transmembranprotein kodierendes humanes autismus-suszeptibilitätsgen und dessen verwendung
|
US20060234347A1
(en)
*
|
2005-04-13 |
2006-10-19 |
Harding Thomas C |
Targeting multiple angiogenic pathways for cancer therapy using soluble tyrosine kinase receptors
|
DK2002003T3
(en)
|
2005-05-27 |
2016-03-21 |
Ospedale San Raffaele Srl |
Gene vector comprising miRNA
|
EP1910550A4
(en)
|
2005-07-21 |
2009-11-04 |
Abbott Lab |
MULTIGENIC EXPRESSION COMPRISING SORF CONSTRUCTS AND METHODS USING POLYPROTEINS, PRO-PROTEINS, AND PROTEOLYSIS
|
JP2009505680A
(ja)
*
|
2005-08-31 |
2009-02-12 |
ジェンベク、インコーポレイティッド |
アデノウイルスベクターに基づくマラリアワクチン
|
US9651543B2
(en)
|
2005-08-31 |
2017-05-16 |
The United States Of America As Represented By The Secretary Of The Navy |
Malaria antigen screening method
|
US8450055B2
(en)
*
|
2005-08-31 |
2013-05-28 |
The United States Of America As Represented By The Secretary Of The Navy |
Malaria antigen screening method
|
EP1951297A2
(en)
|
2005-11-10 |
2008-08-06 |
GenVec, Inc. |
Adenoviral vector-based foot-and-mouth disease vaccine
|
WO2007104792A2
(en)
*
|
2006-03-16 |
2007-09-20 |
Crucell Holland B.V. |
Recombinant adenoviruses based on serotype 26 and 48, and use thereof
|
EP1835036A1
(en)
|
2006-03-16 |
2007-09-19 |
Exonhit Therapeutics SA |
Methods and compositions for the detection and treatment of cancers
|
JP5238710B2
(ja)
|
2006-10-19 |
2013-07-17 |
シーエスエル、リミテッド |
インターロイキン−13レセプターアルファ1の高親和性抗体アンタゴニスト
|
US8613925B2
(en)
|
2006-10-19 |
2013-12-24 |
Csl Limited |
Anti-IL-13Rα1 antibodies and their uses thereof
|
AR064642A1
(es)
|
2006-12-22 |
2009-04-15 |
Wyeth Corp |
Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
|
EP2114445A2
(en)
*
|
2007-01-09 |
2009-11-11 |
Genvec, Inc. |
Adenoviral vector-based malaria vaccines
|
EP2027868A1
(en)
|
2007-08-24 |
2009-02-25 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Use of SCO-Spondin peptides for inhibiting or preventing neuronal apoptosis mediated by cell death receptor ligands
|
WO2009095478A1
(en)
|
2008-01-31 |
2009-08-06 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies against human cd39 and use thereof for inhibiting t regulatory cells activity
|
EP2355847A1
(en)
|
2008-10-07 |
2011-08-17 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Neutralizing antibodies and fragments thereof directed against platelet factor-4 variant 1 (pf4v1)
|
AU2009313615B2
(en)
|
2008-11-05 |
2012-11-29 |
Regents Of The University Of Minnesota |
Multicomponent immunogenic composition for the prevention of beta-hemolytic streptococcal (BHS) disease
|
JP5833448B2
(ja)
|
2008-12-19 |
2015-12-16 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
セリンプロテアーゼ誘導体および血液凝固疾患の予防または処置における使用
|
EP2199387A1
(en)
|
2008-12-19 |
2010-06-23 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Serine protease derivatives and uses for the prevention and/or the treatment of blood coagulation disorders
|
ES2536747T3
(es)
|
2009-01-20 |
2015-05-28 |
Transgene Sa |
ICAM 1 soluble como biomarcador para predicción de respuesta terapéutica
|
WO2010096561A1
(en)
|
2009-02-18 |
2010-08-26 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Synthetic hiv/siv gag proteins and uses thereof
|
EP2408818A1
(en)
|
2009-03-17 |
2012-01-25 |
Université de la Méditerranée |
Btla antibodies and uses thereof
|
NZ595290A
(en)
|
2009-03-24 |
2012-09-28 |
Transgene Sa |
Biomarker for monitoring patients
|
RU2555340C2
(ru)
|
2009-04-17 |
2015-07-10 |
Трансжене Са |
Биомаркер для мониторинга пациентов
|
EP2427205A2
(en)
|
2009-05-04 |
2012-03-14 |
INSERM - Institut National de la Santé et de la Recherche Médicale |
Par2 agonists for use in the treatment or prevention of influenza virus type a infections
|
US9187568B2
(en)
|
2009-05-07 |
2015-11-17 |
Stallergenes S.A. |
Use of IgG1 immunoglobulins and/or ligands of the CD32 receptor for treating inflammatory diseases and manifestations via the mucosal route
|
US9050276B2
(en)
|
2009-06-16 |
2015-06-09 |
The Trustees Of Columbia University In The City Of New York |
Autism-associated biomarkers and uses thereof
|
JP5650212B2
(ja)
|
2009-07-10 |
2015-01-07 |
トランジェーヌ、ソシエテ、アノニムTransgene S.A. |
患者を選択するためのバイオマーカーおよび関連方法
|
WO2011047316A1
(en)
|
2009-10-16 |
2011-04-21 |
The United States Of America, As Represented By The Secretary Department Of Health And Human Services |
Nucleic acid sequences encoding expandable hiv mosaic proteins
|
WO2011048443A1
(en)
|
2009-10-20 |
2011-04-28 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Neuronal exocytosis inhibiting peptides derived from c subunit of v-atpase and cosmetic and pharmaceutical compositions containing said peptides
|
AU2010313395A1
(en)
|
2009-10-30 |
2012-05-10 |
Abbvie Inc. |
sORF constructs and multiple gene expression
|
JP5980117B2
(ja)
|
2009-11-09 |
2016-08-31 |
ジェンヴェック,インコーポレーテッド |
サルアデノウイルスベクターの増殖方法
|
WO2011057254A2
(en)
|
2009-11-09 |
2011-05-12 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Simian adenoviral vector-based vaccines
|
WO2011080322A1
(en)
|
2009-12-30 |
2011-07-07 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Method of prognosing the outcome of acquired hemophilia and of treatment of hemophilia
|
EP2524226A1
(en)
|
2010-01-13 |
2012-11-21 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Promyelocytic leukemia protein as a redox sensor
|
KR20110103119A
(ko)
*
|
2010-03-12 |
2011-09-20 |
국립암센터 |
신규한 조건부-복제 가능 아데노바이러스 및 그의 제조 방법
|
ES2887335T3
(es)
|
2010-03-17 |
2021-12-22 |
Univ Cornell |
Vacuna contra las drogas de abuso basada en adenovirus alterado
|
ES2805301T3
(es)
|
2010-04-08 |
2021-02-11 |
Inst Nat Sante Rech Med |
Péptidos inhibidores derivados del transcrito de tipo TREM-1 (TLT-1) y sus usos
|
US8853158B2
(en)
|
2010-05-25 |
2014-10-07 |
Institut National De La Santé Et De La Recherche Médicale (Inserm) |
Methods for the treatment of a feeding disorder with onset during neonate development using an agonist of the oxytocin receptor
|
WO2012004416A2
(en)
|
2010-07-09 |
2012-01-12 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Treatment of a disease associated with retinal degenerative disorder
|
WO2012010696A1
(en)
|
2010-07-23 |
2012-01-26 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for cancer management targeting co-029
|
WO2012021730A2
(en)
|
2010-08-11 |
2012-02-16 |
Genvec, Inc. |
Respiratory syncytial virus (rsv) vaccine
|
ES2850973T3
(es)
|
2010-08-23 |
2021-09-01 |
Wyeth Llc |
Formulaciones estables de antígenos rLP2086 de Neisseria meningitidis
|
WO2012032489A1
(en)
|
2010-09-10 |
2012-03-15 |
Wyeth Llc |
Non-lipidated variants of neisseria meningitidis orf2086 antigens
|
JP5937088B2
(ja)
|
2010-10-15 |
2016-06-22 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
ハンチントン病の治療法におけるコレステロール−24−ヒドロラーゼのための発現ベクター
|
WO2012080769A1
(en)
|
2010-12-15 |
2012-06-21 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Anti-cd277 antibodies and uses thereof
|
WO2012083297A2
(en)
|
2010-12-17 |
2012-06-21 |
Genvec, Inc. |
Adenoviral vectors with modified hexon regions
|
WO2012088041A1
(en)
|
2010-12-20 |
2012-06-28 |
Genvec, Inc. |
Adenoviral vector-based dengue fever vaccine
|
WO2012085132A1
(en)
|
2010-12-22 |
2012-06-28 |
Orega Biotech |
Antibodies against human cd39 and use thereof
|
US9598499B2
(en)
|
2010-12-30 |
2017-03-21 |
Institut National De La Santé Et De La Recherche Médicale (Inserm) |
Antigen binding formats for use in therapeutic treatments or diagnostic assays
|
WO2012101125A1
(en)
|
2011-01-24 |
2012-08-02 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Specific antibodies against human cxcl4 and uses thereof
|
WO2012120131A1
(en)
|
2011-03-09 |
2012-09-13 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for generating cell microparticles
|
WO2012120129A1
(en)
|
2011-03-10 |
2012-09-13 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical composition for the treatment of infectious diseases
|
JP6220774B2
(ja)
|
2011-03-31 |
2017-10-25 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
Icosに対する抗体及びその使用
|
DK2707391T3
(en)
|
2011-05-13 |
2018-02-05 |
Gamamabs Pharma |
ANTIBODIES AGAINST HER3
|
CN103890010B
(zh)
|
2011-05-19 |
2017-04-19 |
法国国家健康医学研究院 |
抗‑人‑her3抗体及其用途
|
WO2012162428A1
(en)
|
2011-05-23 |
2012-11-29 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Prime-boost vaccination for viral infection
|
WO2012172074A1
(en)
|
2011-06-15 |
2012-12-20 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Polypeptides isolated from brevibacterium aurantiacum and their use for the treatment of cancer
|
BR112013032899A2
(pt)
|
2011-06-22 |
2017-01-24 |
Inserm Inst Nat De La Santé Et De La Rech Médicale |
anticorpos anti-axl e utilizações dos mesmos
|
CA2839508A1
(en)
|
2011-06-22 |
2012-12-27 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Anti-axl antibodies and uses thereof
|
EP2543678A1
(en)
|
2011-07-08 |
2013-01-09 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies for the treatment and prevention of thrombosis
|
EP2543677A1
(en)
|
2011-07-08 |
2013-01-09 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies for the treatment and prevention of thrombosis
|
EP2543679A1
(en)
|
2011-07-08 |
2013-01-09 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies for the treatment and prevention of thrombosis
|
FR2979346B1
(fr)
|
2011-08-23 |
2013-09-27 |
Univ Joseph Fourier |
Nanocorps anti-vcam-1
|
WO2013041901A1
(en)
|
2011-09-20 |
2013-03-28 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for preparing single domain antibody microarrays
|
EP2764011B1
(en)
|
2011-10-05 |
2021-04-07 |
GenVec, Inc. |
Adenoviral vector-based respiratory syncytial virus (rsv) vaccine
|
BR112014008249B1
(pt)
|
2011-10-05 |
2022-03-15 |
Genvec Inc |
Adenovírus ou vetor adenoviral e composição com os mesmos
|
US9233153B2
(en)
|
2011-10-05 |
2016-01-12 |
Genvec, Inc. |
Affenadenovirus (gorilla) or adenoviral vectors and methods of use
|
BR112014008284A2
(pt)
|
2011-10-05 |
2020-10-27 |
Genvec Inc. |
adenovirus (gorilla) simian ou vetores adenovirais e métodos de uso
|
US20150157700A1
(en)
|
2012-02-02 |
2015-06-11 |
GanVec, Inc. |
Adenoviral vector-based malaria vaccine
|
WO2013119880A1
(en)
|
2012-02-07 |
2013-08-15 |
Global Bio Therapeutics Usa, Inc. |
Compartmentalized method of nucleic acid delivery and compositions and uses thereof
|
NZ628449A
(en)
|
2012-03-09 |
2016-04-29 |
Pfizer |
Neisseria meningitidis compositions and methods thereof
|
SA115360586B1
(ar)
|
2012-03-09 |
2017-04-12 |
فايزر انك |
تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
|
US10039777B2
(en)
|
2012-03-20 |
2018-08-07 |
Neuro-Lm Sas |
Methods and pharmaceutical compositions of the treatment of autistic syndrome disorders
|
WO2013174835A1
(en)
|
2012-05-22 |
2013-11-28 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for screening a candidate compound for its pharmacology on a nuclear receptor
|
EP2855678B1
(en)
|
2012-05-25 |
2017-08-23 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for selecting binders by phage display and masked selection
|
EP2855669B1
(en)
|
2012-05-29 |
2018-10-10 |
GenVec, Inc. |
Modified serotype 28 adenoviral vectors
|
US9676824B2
(en)
|
2012-05-29 |
2017-06-13 |
Genvec, Inc. |
Herpes simplex virus vaccine
|
US9676847B2
(en)
|
2012-06-25 |
2017-06-13 |
Orega Biotech |
IL-17 antagonist antibodies
|
EP2692732A1
(en)
|
2012-08-03 |
2014-02-05 |
Stallergenes S.A. |
Novel allergen from ragweed pollen and uses thereof
|
EP2892928B1
(en)
|
2012-09-03 |
2018-05-30 |
INSERM - Institut National de la Santé et de la Recherche Médicale |
Antibodies directed against icos for treating graft-versus-host disease
|
DK2892920T3
(da)
|
2012-09-07 |
2020-06-08 |
Inst Nat Sante Rech Med |
Hæmmende peptider afledt af udløsningsreceptor udtrykt på myeloide celler-1 (trem-1) trem-lignende transskript 1 (tlt-1) og anvendelser deraf
|
ES2752190T3
(es)
|
2012-09-14 |
2020-04-03 |
Us Health |
Proteína Brachyury, vectores adenovirales que codifican proteína Brachyury y su uso
|
KR101522341B1
(ko)
*
|
2012-10-02 |
2015-05-21 |
국립암센터 |
신규한 조건부-복제 가능 아데노바이러스 및 그의 제조 방법
|
US20160083712A1
(en)
|
2012-10-12 |
2016-03-24 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Csn5 polypeptides and uses thereof for screening therapeutic agents
|
EP2733153A1
(en)
|
2012-11-15 |
2014-05-21 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for the preparation of immunoconjugates and uses thereof
|
CA2889962C
(en)
|
2012-11-20 |
2023-10-24 |
Sanofi |
Anti-ceacam5 antibodies and uses thereof
|
US11013783B2
(en)
|
2012-12-26 |
2021-05-25 |
Institut National De Recherche Pour L'agriculture, L'alimentation Et L'environnement |
Anti-inflammatory peptides and methods for treating inflammatory diseases
|
EP2749289A1
(en)
|
2012-12-26 |
2014-07-02 |
Institut National De La Recherche Agronomique (INRA) |
Anti-inflammatory peptides
|
EA201690004A1
(ru)
|
2012-12-27 |
2016-07-29 |
Санофи |
Антитела против lamp1 и конъюгаты антитела и лекарственного средства, а также их применение
|
WO2014107739A1
(en)
|
2013-01-07 |
2014-07-10 |
Eleven Biotherapeutics, Inc. |
Antibodies against pcsk9
|
US9066966B2
(en)
|
2013-02-01 |
2015-06-30 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Methods and pharmaceutical compositions for the treatment of cardiomyopathy due to friedreich ataxia
|
JP6446377B2
(ja)
|
2013-03-08 |
2018-12-26 |
ファイザー・インク |
免疫原性融合ポリペプチド
|
CA2940513C
(en)
|
2013-03-11 |
2023-08-15 |
University Of Florida Research Foundation, Inc. |
Delivery of card protein as therapy for ocular inflammation
|
DE102013004595A1
(de)
|
2013-03-15 |
2014-09-18 |
Emergent Product Development Germany Gmbh |
RSV-Impfstoffe
|
KR101606910B1
(ko)
|
2013-03-29 |
2016-04-04 |
충북보건과학대학교 산학협력단 |
아데노바이러스 벡터 생산용 a549 기반 세포주
|
JP6474797B2
(ja)
|
2013-06-27 |
2019-02-27 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
インターロイキン15(il−15)アンタゴニスト並びに自己免疫疾患及び炎症性疾患の処置のためのその使用
|
EP2824176A1
(en)
|
2013-07-11 |
2015-01-14 |
Siamed'xpress |
Methods for producing sialylated therapeutic proteins
|
US11364032B2
(en)
|
2013-08-08 |
2022-06-21 |
Global Bio Therapeutics, Inc. |
Clamp device for minimally invasive procedures and uses thereof
|
CA2923129C
(en)
|
2013-09-08 |
2020-06-09 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
EP3066203B2
(en)
|
2013-11-05 |
2023-11-08 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New alzheimer's disease animal model
|
WO2015067986A1
(en)
|
2013-11-07 |
2015-05-14 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Neuregulin allosteric anti-her3 antibody
|
KR20160108540A
(ko)
|
2014-01-20 |
2016-09-19 |
사노피 |
증가된 효소 활성을 갖는 신규한 시토크롬 p450 폴리펩티드
|
EP3107939B1
(en)
|
2014-02-19 |
2020-06-17 |
University of Florida Research Foundation, Inc. |
Delivery of nrf2 as therapy for protection against reactive oxygen species
|
WO2015158851A1
(en)
|
2014-04-16 |
2015-10-22 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies for the prevention or the treatment of bleeding episodes
|
FR3020063A1
(fr)
|
2014-04-16 |
2015-10-23 |
Gamamabs Pharma |
Anticorps humain anti-her4
|
US10189887B2
(en)
|
2014-04-17 |
2019-01-29 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Polypeptides and uses thereof for reducing CD95-mediated cell motility
|
FR3021970B1
(fr)
|
2014-06-06 |
2018-01-26 |
Universite Sciences Technologies Lille |
Anticorps dirige contre la galectine 9 et inhibiteur de l'activite suppressive des lymphocytes t regulateurs
|
EP2974735A1
(en)
|
2014-07-15 |
2016-01-20 |
Institut National De La Recherche Agronomique (INRA) |
Anti-inflammatory properties of a surface protein of propionibacterium freudenreichii
|
WO2016037154A1
(en)
|
2014-09-04 |
2016-03-10 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Recombinant hiv-1 envelope proteins and their use
|
EP3229836B1
(en)
|
2014-12-09 |
2019-11-13 |
Institut National de la Sante et de la Recherche Medicale (INSERM) |
Human monoclonal antibodies against axl
|
EP3236998A1
(en)
|
2014-12-24 |
2017-11-01 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Recombinant metapneumovirus f proteins and their use
|
JP7020917B2
(ja)
|
2015-01-20 |
2022-02-16 |
ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
キメラrsv/bpiv3 fタンパクを発現する組換えヒト/ウシパラインフルエンザウイルス3(b/hpiv3)およびその使用
|
UA126269C2
(uk)
|
2015-01-23 |
2022-09-14 |
Санофі |
АНТИТІЛОПОДІБНИЙ ЗВ’ЯЗУВАЛЬНИЙ БІЛОК, ЯКИЙ СПЕЦИФІЧНО ЗВ’ЯЗУЄТЬСЯ З ПОЗАКЛІТИННИМ ДОМЕНОМ CD3<font face="Symbol">e</font> ЛЮДИНИ І З CD123<font face="Symbol">e</font>
|
BR112017017460A2
(pt)
|
2015-02-19 |
2018-04-10 |
Pfizer Inc. |
composições de neisseria meningitidis e métodos das mesmas
|
EP3261665A1
(en)
|
2015-02-24 |
2018-01-03 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Middle east respiratory syndrome coronavirus immunogens, antibodies, and their use
|
WO2016135041A1
(en)
|
2015-02-26 |
2016-09-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Fusion proteins and antibodies comprising thereof for promoting apoptosis
|
WO2016150964A1
(en)
|
2015-03-23 |
2016-09-29 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical composition for the treatment and the prevention of neurological phenotype associated with friedreich ataxia
|
EP3091033A1
(en)
|
2015-05-06 |
2016-11-09 |
Gamamabs Pharma |
Anti-human-her3 antibodies and uses thereof
|
US20180125947A1
(en)
|
2015-05-20 |
2018-05-10 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Treatment of retinal detachment
|
EP3298044B1
(en)
|
2015-05-22 |
2021-08-25 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Human monoclonal antibodies fragments inhibiting both the cath-d catalytic activity and its binding to the lrp1 receptor
|
US20180201687A1
(en)
|
2015-07-07 |
2018-07-19 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies having specificity to myosin 18a and uses thereof
|
CN108289940B
(zh)
|
2015-08-03 |
2023-01-13 |
美国卫生和人力服务部 |
Brachyury缺失突变体、编码brachyury缺失突变体的非酵母载体及其用途
|
WO2017029391A1
(en)
|
2015-08-20 |
2017-02-23 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New method for treating cancer
|
WO2017046200A1
(en)
|
2015-09-16 |
2017-03-23 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Specific interleukin-15 (il-15) antagonist polypeptide and uses thereof for the treatment of inflammatory and auto-immune diseases
|
US10647752B2
(en)
|
2015-09-22 |
2020-05-12 |
Inserm (Institut National De La Santé Et De La Recherche Medicale) |
Polypeptides capable of inhibiting the binding between leptin and Neuropilin-1
|
WO2017050955A1
(en)
|
2015-09-24 |
2017-03-30 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Agents capable of inhibiting the binding between leptin and vegf165
|
ES2907486T3
(es)
|
2015-09-24 |
2022-04-25 |
Univ North Carolina Chapel Hill |
Métodos y composiciones para reducir metástasis
|
CN109069671B
(zh)
|
2016-01-19 |
2022-10-18 |
加利福尼亚大学董事会 |
Danon病和其它自噬障碍的治疗方法
|
WO2017139392A1
(en)
|
2016-02-08 |
2017-08-17 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Recombinant hiv-1 envelope proteins and their use
|
US20230183346A1
(en)
|
2016-02-26 |
2023-06-15 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Antibodies having specificity for btla and uses thereof
|
WO2017156272A1
(en)
|
2016-03-09 |
2017-09-14 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Recombinant hiv-1 envelope proteins and their use
|
WO2017162678A1
(en)
|
2016-03-22 |
2017-09-28 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Humanized anti-claudin-1 antibodies and uses thereof
|
WO2017172772A1
(en)
|
2016-03-28 |
2017-10-05 |
Dimension Therapeutics |
Methods of heat inactivation of adenovirus
|
WO2018013705A1
(en)
*
|
2016-07-12 |
2018-01-18 |
Dimension Therapeutics |
Use of glucocorticoid analogs to enhance recombinant adeno-associated virus yield
|
TWI790206B
(zh)
|
2016-07-18 |
2023-01-21 |
法商賽諾菲公司 |
特異性結合至cd3和cd123的雙特異性抗體樣結合蛋白
|
US11186634B2
(en)
|
2016-07-29 |
2021-11-30 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies targeting tumor associated macrophages and uses thereof
|
EP3512540A1
(en)
|
2016-09-14 |
2019-07-24 |
Université Catholique de Louvain |
Modified vsv-g and vaccines thereof
|
TW201823467A
(zh)
|
2016-09-20 |
2018-07-01 |
德商百靈佳殷格翰維美迪加股份有限公司 |
犬腺病毒載體
|
NZ751966A
(en)
|
2016-09-20 |
2023-03-31 |
Boehringer Ingelheim Vetmedica Gmbh |
New promoters
|
TWI817933B
(zh)
|
2016-09-20 |
2023-10-11 |
德商百靈佳殷格翰維美迪加股份有限公司 |
新穎ehv插入位點orf70
|
WO2018054822A1
(en)
|
2016-09-20 |
2018-03-29 |
Boehringer Ingelheim Vetmedica Gmbh |
New swine influenza vaccine
|
CA3038968A1
(en)
|
2016-09-30 |
2018-04-05 |
Genvec, Inc. |
Adenovectors for delivery of therapeutic genetic material into t cells
|
US11602559B2
(en)
|
2016-10-03 |
2023-03-14 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
HIV-1 Env fusion peptide immunogens and their use
|
WO2018071817A1
(en)
|
2016-10-14 |
2018-04-19 |
Dimension Therapeutics |
Use of tonicifying agents to enhance recombinant adeno-associated virus yield
|
US11286295B2
(en)
|
2016-10-20 |
2022-03-29 |
Sanofi |
Anti-CHIKV monoclonal antibodies directed against the E2 structural protein
|
EP3532095A1
(en)
|
2016-10-25 |
2019-09-04 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Prefusion coronavirus spike proteins and their use
|
WO2018077926A1
(en)
|
2016-10-25 |
2018-05-03 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Monoclonal antibodies binding to the cd160 transmembrane isoform
|
FR3058143B1
(fr)
|
2016-10-27 |
2021-03-12 |
Univ Grenoble Alpes |
Nanocorps anti-tau
|
MX2019005235A
(es)
|
2016-11-09 |
2019-12-05 |
Intrexon Corp |
Constructos de expresion de frataxina.
|
MX2019006349A
(es)
|
2016-12-16 |
2019-08-22 |
Inst Res Biomedicine |
Proteinas recombinantes rsv f de prefusion nuevas y usos de las mismas.
|
EP3574091B1
(en)
|
2017-01-30 |
2023-02-22 |
Brainvectis |
Expression vector for cholesterol 24-hydrolase in therapy of polyglutamine repeat spinocerebellar ataxias
|
CN110234658B
(zh)
|
2017-01-31 |
2024-03-12 |
辉瑞大药厂 |
脑膜炎奈瑟菌组合物及其使用方法
|
WO2018158398A1
(en)
|
2017-03-02 |
2018-09-07 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies having specificity to nectin-4 and uses thereof
|
JP7308150B2
(ja)
|
2017-03-16 |
2023-07-13 |
イナート・ファルマ・ソシエテ・アノニム |
癌を処置するための組成物及び方法
|
JP7142643B2
(ja)
|
2017-03-22 |
2022-09-27 |
ウルトラジェニックス ファーマシューティカル インコーポレイテッド |
Hdac阻害剤またはrepタンパク質を伴う細胞培養方法
|
US11235056B2
(en)
|
2017-03-24 |
2022-02-01 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Glycan-masked engineered outer domains of HIV-1 gp120 and their use
|
WO2018178051A1
(en)
|
2017-03-28 |
2018-10-04 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Scgb1a1 polymorphism for the prediction and therapy or prevention of primary graft dysfunction
|
EP3388072A1
(en)
|
2017-04-10 |
2018-10-17 |
Universität Leipzig |
Ubiquinone-independent cytoplasmic dihydroorotate dehydrogenase for use as medicament
|
CN110914414A
(zh)
|
2017-06-14 |
2020-03-24 |
德累斯顿工业大学 |
利用设计dna重组酶遗传改变基因组的方法与手段
|
US11174322B2
(en)
|
2017-07-24 |
2021-11-16 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies and peptides to treat HCMV related diseases
|
WO2019038420A1
(en)
|
2017-08-25 |
2019-02-28 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF OSTEOCLAST DISEASES
|
JP7226833B2
(ja)
|
2017-09-21 |
2023-02-21 |
イムチェック セラピューティクス エスエーエス |
Btn2に特異性を有する抗体及びその使用
|
US11136356B2
(en)
|
2017-10-16 |
2021-10-05 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Recombinant HIV-1 envelope proteins and their use
|
JP7502991B2
(ja)
|
2017-10-16 |
2024-06-19 |
ボイジャー セラピューティクス インコーポレイテッド |
筋萎縮性側索硬化症(als)の治療
|
US20200237799A1
(en)
|
2017-10-16 |
2020-07-30 |
Voyager Therapeutics, Inc. |
Treatment of amyotrophic lateral sclerosis (als)
|
AU2019231652A1
(en)
|
2018-03-06 |
2020-10-01 |
Precigen, Inc. |
Hepatitis B vaccines and uses of the same
|
CN112334486A
(zh)
|
2018-06-18 |
2021-02-05 |
先天制药公司 |
用于治疗癌症的组合物和方法
|
JP2021529513A
(ja)
|
2018-07-02 |
2021-11-04 |
ボイジャー セラピューティクス インコーポレイテッドVoyager Therapeutics,Inc. |
筋萎縮性側索硬化症および脊髄に関連する障害の治療
|
WO2020010035A1
(en)
|
2018-07-02 |
2020-01-09 |
Voyager Therapeutics, Inc. |
Cannula system
|
AU2019368218A1
(en)
|
2018-10-22 |
2021-05-27 |
New York University |
Recombinant GP120 protein with V1-loop deletion
|
FI3873511T3
(sv)
|
2018-10-29 |
2023-01-31 |
|
Uttrycksvektor för kolesterol-24-hydrolas vid behandling av amyotrofisk lateralskleros
|
WO2020148207A1
(en)
|
2019-01-14 |
2020-07-23 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Human monoclonal antibodies binding to hla-a2
|
KR20210121077A
(ko)
|
2019-01-15 |
2021-10-07 |
인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) |
돌연변이된 인터루킨-34 (il-34) 폴리펩티드 및 요법에서의 이의 용도
|
SG11202109932WA
(en)
|
2019-03-20 |
2021-10-28 |
Imcheck Therapeutics Sas |
Antibodies having specificity for btn2 and uses thereof
|
EP3942026A1
(en)
|
2019-03-22 |
2022-01-26 |
Université de Paris |
New inhibitors of lrrk2/pp1 interaction
|
CN113631573B
(zh)
|
2019-03-25 |
2024-06-04 |
国家医疗保健研究所 |
抗Tau抗体及其在制备用于治疗疾病的药物中的用途
|
JP2022538733A
(ja)
|
2019-05-20 |
2022-09-06 |
インセルム(インスティチュート ナショナル デ ラ サンテ エ デ ラ リシェルシェ メディカル) |
新規抗cd25抗体
|
JP2022534202A
(ja)
|
2019-05-21 |
2022-07-28 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
レット症候群の治療におけるコレステロール 24-ヒドロラーゼのための発現ベクター
|
EP3986453A1
(en)
|
2019-06-20 |
2022-04-27 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Anti- protease nexin-1 conformational single domain antibodies and uses thereof
|
US20220251567A1
(en)
|
2019-07-10 |
2022-08-11 |
Inserm (Institut National De La Santè Et De La Recherche Médicale) |
Methods for the treatment of epilepsy
|
US20220251234A1
(en)
|
2019-07-16 |
2022-08-11 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies having specificity for cd38 and uses thereof
|
WO2021009299A1
(en)
|
2019-07-17 |
2021-01-21 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Bcl-xl:fkbp12 fusion proteins suitable for screening agents capable of slowing down the aging process
|
DE102019121007A1
(de)
|
2019-08-02 |
2021-02-04 |
Immatics Biotechnologies Gmbh |
Antigenbindende Proteine, die spezifisch an MAGE-A binden
|
US20210032370A1
(en)
|
2019-08-02 |
2021-02-04 |
Immatics Biotechnologies Gmbh |
Recruiting agent further binding an mhc molecule
|
JP2022543259A
(ja)
|
2019-08-02 |
2022-10-11 |
オレガ・バイオテック |
新規il-17b抗体
|
WO2021028837A1
(en)
|
2019-08-13 |
2021-02-18 |
Waters Technologies Corporation |
Affinity resins and sample preparation devices based on cartilaginous fish ignar derived binding domains
|
US20220265659A1
(en)
|
2019-09-02 |
2022-08-25 |
Inserm (Institut National De La Santé Et De Al Recherche Médicale) |
Methods and compositions for treating pax6-deficiency related disease
|
KR20220084033A
(ko)
|
2019-09-04 |
2022-06-21 |
인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) |
Il20-rb에 대해 특이적인 항체 및 만성 폐쇄성 폐 질환의 급성 악화를 치료하기 위한 이의 용도
|
WO2021048171A1
(en)
|
2019-09-10 |
2021-03-18 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Method to improve phagocytosis
|
CA3154655A1
(en)
|
2019-09-24 |
2021-04-01 |
Universite Catholique De Louvain |
Modified vesicular stomatitis virus glycoprotein and uses thereof for the treatment of brain tumors
|
CN114450304B
(zh)
|
2019-09-27 |
2023-12-12 |
国家医疗保健研究所 |
抗苗勒管抑制物质抗体及其用途
|
WO2021058729A1
(en)
|
2019-09-27 |
2021-04-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Anti-müllerian inhibiting substance type i receptor antibodies and uses thereof
|
AU2020361533A1
(en)
|
2019-10-08 |
2022-04-28 |
Trustees Of Boston College |
Proteins containing multiple, different unnatural amino acids and methods of making and using such proteins
|
EP3812008A1
(en)
|
2019-10-23 |
2021-04-28 |
Gamamabs Pharma |
Amh-competitive antagonist antibody
|
CN110656090B
(zh)
*
|
2019-10-28 |
2023-06-30 |
嘉兴安宇生物科技有限公司 |
一种表达质粒、用于包装容量增加的二代腺病毒的细胞株及其应用
|
CN110714027A
(zh)
*
|
2019-10-28 |
2020-01-21 |
嘉铭(固安)生物科技有限公司 |
一种表达质粒、用于包装二代腺病毒的细胞株及其应用
|
WO2021099394A1
(en)
|
2019-11-19 |
2021-05-27 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antisense oligonucleotides and their use for the treatment of cancer
|
CN114787181A
(zh)
|
2019-11-21 |
2022-07-22 |
Inserm(法国国家健康医学研究院) |
用抗pd-1/il-15免疫细胞因子靶向pd-1的新型免疫疗法
|
EP4072682A1
(en)
|
2019-12-09 |
2022-10-19 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
Antibodies having specificity to her4 and uses thereof
|
EP4090365A1
(en)
|
2020-01-15 |
2022-11-23 |
Immatics Biotechnologies GmbH |
Antigen binding proteins specifically binding prame
|
CA3165713A1
(en)
|
2020-01-30 |
2021-08-05 |
Andrew Scharenberg |
Bispecific transduction enhancer
|
EP4103229A1
(en)
|
2020-02-11 |
2022-12-21 |
The United States of America, as represented by the Secretary, Department of Health and Human Services |
Sars-cov-2 vaccine
|
WO2021175954A1
(en)
|
2020-03-04 |
2021-09-10 |
Imcheck Therapeutics Sas |
Antibodies having specificity for btnl8 and uses thereof
|
US11213482B1
(en)
|
2020-03-05 |
2022-01-04 |
University of Pittsburgh—Of the Commonwealth System of Higher Educat |
SARS-CoV-2 subunit vaccine and microneedle array delivery system
|
CA3170369A1
(en)
|
2020-03-05 |
2022-04-14 |
Michal Shahar |
Methods and compositions for treating cancer with immune cells
|
US11773391B2
(en)
|
2020-04-01 |
2023-10-03 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Therapeutic and diagnostic target for SARS-CoV-2 and COVID-19
|
EP4142785A2
(en)
|
2020-04-29 |
2023-03-08 |
The United States of America, as represented by the Secretary, Department of Health and Human Services |
Recombinant human metapneumovirus f proteins and their use
|
KR20230008751A
(ko)
|
2020-05-12 |
2023-01-16 |
인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) |
피부 t-세포 림프종 및 tfh 유래된 림프종을 치료하는 신규한 방법
|
WO2021247995A2
(en)
|
2020-06-04 |
2021-12-09 |
Voyager Therapeutics, Inc. |
Compositions and methods of treating neuropathic pain
|
CA3187283A1
(en)
|
2020-06-29 |
2022-01-06 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Anti-protein s single-domain antibodies and polypeptides comprising thereof
|
CN116194154A
(zh)
|
2020-08-07 |
2023-05-30 |
太空飞船七有限责任公司 |
使用aav载体的plakophilin-2(pkp2)基因疗法
|
WO2022035860A2
(en)
|
2020-08-10 |
2022-02-17 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Replication-competent adenovirus type 4-hiv env vaccines and their use
|
AU2021335257A1
(en)
|
2020-09-04 |
2023-03-09 |
Merck Patent Gmbh |
Anti-CEACAM5 antibodies and conjugates and uses thereof
|
MX2023005570A
(es)
|
2020-11-12 |
2023-05-29 |
Inst Nat Sante Rech Med |
Anticuerpos conjugados o fusionados al dominio de union del receptor de la proteina de la espicula de sars-cov-2 y usos de los mismos con fines de vacunacion.
|
EP4267176A1
(en)
|
2020-12-23 |
2023-11-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Chlamydia vaccine based on targeting momp vs4 antigen to antigen presenting cells
|
WO2022152698A1
(en)
|
2021-01-12 |
2022-07-21 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Use of npdk-d to evaluate cancer prognosis
|
WO2022159575A1
(en)
|
2021-01-20 |
2022-07-28 |
Bioentre Llc |
Ctla4-binding proteins and methods of treating cancer
|
BR112023014980A2
(pt)
|
2021-01-27 |
2023-10-10 |
Umoja Biopharma Inc |
Lentivírus para gerar células que expressam o receptor de antígeno quimérico anti-cd19
|
CN117157320A
(zh)
|
2021-01-29 |
2023-12-01 |
国家健康科学研究所 |
沙眼衣原体抗原性多肽及其用于疫苗目的的用途
|
WO2022184805A1
(en)
|
2021-03-03 |
2022-09-09 |
Immatics Biotechnologies Gmbh |
Antigen binding proteins specifically binding sars-cov-2 antigenic peptides in complex with a major histocompatibility complex protein
|
WO2022200469A1
(en)
|
2021-03-24 |
2022-09-29 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
A dominant negative protein of rad51 for treating cancer
|
WO2022219080A1
(en)
|
2021-04-14 |
2022-10-20 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New method to improve nk cells cytotoxicity
|
WO2022219076A1
(en)
|
2021-04-14 |
2022-10-20 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New method to improve the anti-tumoral activity of macrophages
|
WO2022232648A1
(en)
|
2021-04-29 |
2022-11-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Prefusion-stabilized lassa virus glycoprotein complex and its use
|
IL308018A
(en)
|
2021-04-30 |
2023-12-01 |
Kalivir Immunotherapeutics Inc |
Oncolytic viruses for different MHC expression
|
JP2024518378A
(ja)
|
2021-05-05 |
2024-05-01 |
イマティクス バイオテクノロジーズ ゲーエムベーハー |
Prameに特異的に結合する抗原結合タンパク質
|
EP4337245A1
(en)
|
2021-05-13 |
2024-03-20 |
Universidade Do Algarve |
Isolated or artificial nucleotide sequences for use in neurodegenerative diseases
|
KR20240038028A
(ko)
|
2021-07-27 |
2024-03-22 |
이매틱스 바이오테크놀로지스 게엠베하 |
Ct45에 특이적으로 결합하는 항원 결합 단백질
|
EP4381069A1
(en)
|
2021-08-02 |
2024-06-12 |
Universite De Montpellier |
Compositions and methods for treating cmt1a or cmt1e diseases with rnai molecules targeting pmp22
|
EP4380613A1
(en)
|
2021-08-03 |
2024-06-12 |
The United States of America, as represented by the Secretary, Department of Health and Human Services |
Hiv-1 vaccination and samt-247 microbicide to prevent hiv-1 infection
|
EP4130038A1
(en)
|
2021-08-03 |
2023-02-08 |
Institut national de recherche pour l'agriculture, l'alimentation et l'environnement |
Anti-il-2 antibody, complex comprising it, and uses thereof
|
CN118139655A
(zh)
|
2021-08-13 |
2024-06-04 |
特里奥万斯控股公司 |
皮肤替代组合物及其产生和使用方法
|
WO2023069987A1
(en)
|
2021-10-20 |
2023-04-27 |
University Of Rochester |
Rejuvenation treatment of age-related white matter loss cross reference to related application
|
WO2023081633A1
(en)
|
2021-11-02 |
2023-05-11 |
University Of Rochester |
Tcf7l2 mediated remyelination in the brain
|
US20230183713A1
(en)
|
2021-11-15 |
2023-06-15 |
Technische Universität Dresden |
Site-specific recombinases for efficient and specific genome editing
|
WO2023088968A1
(en)
|
2021-11-17 |
2023-05-25 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Universal sarbecovirus vaccines
|
WO2023091696A1
(en)
|
2021-11-19 |
2023-05-25 |
Christiana Care Gene Editing Institute, Inc. |
Adenovirus delivery system for cancer treatment
|
WO2023099578A1
(en)
|
2021-12-01 |
2023-06-08 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Neutralizing anti-cd95l monoclonal antibodies
|
EP4209508A1
(en)
|
2022-01-11 |
2023-07-12 |
Centre national de la recherche scientifique |
Nanobodies for the deneddylating enzyme nedp1
|
WO2023150563A1
(en)
|
2022-02-01 |
2023-08-10 |
Cornell University |
Methods and pharmaceutical compositions for the treatment and the prevention of cardiomyopathy associated with friedreich ataxia
|
WO2023156437A1
(en)
|
2022-02-16 |
2023-08-24 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Anti-robo4 human monoclonal antibodies and uses thereof for the treatment of cancer
|
WO2023161412A1
(en)
|
2022-02-25 |
2023-08-31 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies for preventing the cleavage of cd95l by metalloproteases
|
WO2023170240A1
(en)
|
2022-03-09 |
2023-09-14 |
Merck Patent Gmbh |
Anti-ceacam5 antibodies and conjugates and uses thereof
|
WO2023170296A1
(en)
|
2022-03-11 |
2023-09-14 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Nucleic acid system to specifically reprogram b and t cells and uses thereof
|
WO2023192835A1
(en)
|
2022-03-27 |
2023-10-05 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Base-covered hiv-1 envelope ectodomains and their use
|
WO2023196898A1
(en)
|
2022-04-07 |
2023-10-12 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Beta globin mimetic peptides and their use
|
WO2023217904A1
(en)
|
2022-05-10 |
2023-11-16 |
Institut National de la Santé et de la Recherche Médicale |
Syncitin-1 fusion proteins and uses thereof for cargo delivery into target cells
|
WO2023240287A1
(en)
|
2022-06-10 |
2023-12-14 |
Bioentre Llc |
Combinations of ctla4 binding proteins and methods of treating cancer
|
WO2024011237A1
(en)
|
2022-07-08 |
2024-01-11 |
Cornell University |
Methods and pharmaceutical compositions for the treatment and the prevention of alzheimers disease
|
WO2024017990A1
(en)
|
2022-07-21 |
2024-01-25 |
Institut National de la Santé et de la Recherche Médicale |
Methods and compositions for treating chronic pain disorders
|
WO2024052503A1
(en)
|
2022-09-08 |
2024-03-14 |
Institut National de la Santé et de la Recherche Médicale |
Antibodies having specificity to ltbp2 and uses thereof
|
WO2024056668A1
(en)
|
2022-09-12 |
2024-03-21 |
Institut National de la Santé et de la Recherche Médicale |
New anti-itgb8 antibodies and its uses thereof
|
WO2024061930A1
(en)
|
2022-09-22 |
2024-03-28 |
Institut National de la Santé et de la Recherche Médicale |
New method to treat and diagnose peripheral t-cell lymphoma (ptcl)
|
WO2024074571A1
(en)
|
2022-10-05 |
2024-04-11 |
Institut National de la Santé et de la Recherche Médicale |
Dc-targeting vaccine against nipah virus infection
|
WO2024079317A1
(en)
|
2022-10-14 |
2024-04-18 |
Institut National de la Santé et de la Recherche Médicale |
Methods and pharmaceutical composition for the treatment of alpha-synucleinopathies
|
PT118269A
(pt)
|
2022-10-20 |
2024-04-22 |
Univ Aveiro |
Pkmyt1 for use in regenerative medicine
|
WO2024091824A1
(en)
|
2022-10-26 |
2024-05-02 |
Ada Forsyth Institute, Inc. |
Differentiation and reprogramming of chondrocyte
|
WO2024097992A2
(en)
|
2022-11-04 |
2024-05-10 |
Umoja Biopharma, Inc. |
Particles displaying adhesion-molecule fusions
|
WO2024098028A2
(en)
|
2022-11-04 |
2024-05-10 |
Umoja Biopharma, Inc. |
Lentiviral particles displaying fusion molecules and uses thereof
|